China Cord Blood Corporation (NYSE: CO) is a life sciences enterprise dedicated to the storage of umbilical cord blood stem cells. Leveraging the rapid developments in life sciences research and the increasing popularity and continuous new developments of clinical applications using stem cells, the Company endeavors to provide umbilical cord blood storage services for parents to save cord blood stem cells on behalf of their children, in China and the Asia Pacific regions, to safeguard the lives and health of their newborns. China Cord Blood Corporation is the first cord blood banking operator approved by the Ministry of Health, the People's Republic of China, to engage in the cord blood banking business. China Cord Blood Corporation provides exclusive cord blood storage services in the Beijing Municipality, the Guangdong Province and the Zhejiang Province. China Cord Blood Corporation is also the largest cord blood banking operator in China, and is one of the founders of the highly recognized non-profit organization - AsiaCORD (Asia Cord Blood Bank) Organization.
>> Webcast Q2 FY2018 China Cord Blood Corp Earnings Conference Call (Replay) 11/21/2017 at 8:00 a.m. ET
Q2 FY2018 China Cord Blood Corp Earnings Conference Call Tuesday, November 21, 2017 8:00 a.m. ET